Technology area: Biotechnology & Pharmaceuticals
16 pending office actions • 9 art units • 13 examiners • 0 of 16 (0%) have an AI response strategy ready • 21 patents granted in the last 365 days
Illumina Cambridge Limited maintains a portfolio with 16 pending office actions, primarily focused within the Biotechnology & Pharmaceuticals technology area. This workload is distributed across 13 distinct examiners and 9 distinct art units, indicating a broad reach across various examination groups. The diversity of 9 distinct art units suggests that the company's innovations intersect with multiple specialized patent classifications.
CROW, ROBERT THOMAS serves as the busiest examiner for the portfolio, currently handling 2 pending office actions. While CROW, ROBERT THOMAS has the highest individual count, the 2 pending actions represent a portion of the 16 total actions pending for the company. This distribution shows that no single examiner dominates the prosecution landscape for Illumina Cambridge Limited. The presence of 13 distinct examiners reflects a strategy where most examiners are managing only a few cases simultaneously.
Based on the USPTO statutory response window for each pending office action. 6 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.
Every pending office action with a known statutory deadline, placed on a days-until-due axis. Dots left of Today are overdue; the further right, the more runway. Cases that share a deadline window stack vertically. 6 of the docket's apps have a known mailing date.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| §101 + other | 1 (6%) |
| §103 only | 1 (6%) |
| Double-patenting only | 1 (6%) |
| Double-patenting + other | 2 (12%) |
| Multi-statute (no §101) | 11 (69%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| CROW, ROBERT THOMAS | 2 | 41.7% | +32.7% |
| BERTAGNA, ANGELA MARIE | 2 | 44.7% | +46.3% |
| PARISI, JESSICA DANIELLE | 2 | 75.8% | +32.3% |
| TSAI, TSUNG YIN | 1 | 81.4% | +11.7% |
| BROWN, MINDY G | 1 | 55.9% | +44.4% |
| HORLICK, KENNETH R | 1 | 78.9% | +15.3% |
| TURK, NEIL N | 1 | 51.0% | +44.3% |
| VANN-OJUEKAIYE, KENDRA RAYCHELL | 1 | 0.0% | +0.0% |
| HIBSHMAN, SARAH GRACE | 1 | 38.9% | +40.0% |
| LU, FRANK WEI MIN | 1 | 62.7% | +67.7% |
Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 8 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18139689 | METHODS AND COMPOSITIONS FOR CLUSTER GENERATION BY BRIDGE AMPLIFICATION | PARISI, JESSICA DANIELLE | 18d overdue |
| 17564592 | METHOD AND SYSTEM EMPLOYING DISTINGUISHABLE POLYMERASES FOR DETECTING TERNARY COMPLEXES AND IDENTIFYING COGNATE NUCLEOTIDES | LU, FRANK WEI MIN | 4d overdue |
| 17478016 | REVERSIBLE MODIFICATION OF NUCLEOTIDES | LEE, HOI YAN NMN | 9d |
| 17946742 | SYSTEMS AND METHODS OF DETECTING DENSELY-PACKED ANALYTES | TURK, NEIL N | 20d |
| 18613562 | DENSLEY-PACKED ANALYTE LAYERS AND DETECTION METHODS | TSAI, TSUNG YIN | 34d |
| 18419082 | COMPOSITIONS AND METHODS FOR AMPLIFYING POLYNUCLEOTIDES | BROWN, MINDY G | — |
| 18303905 | Sequencing Templates Comprising Multiple Inserts and Compositions and Methods for Improving Sequencing Throughput | HORLICK, KENNETH R | — |
| 18169970 | Sequence-Specific Targeted Transposition and Selection and Sorting of Nucleic Acids | PARISI, JESSICA DANIELLE | — |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 8 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18139689 | METHODS AND COMPOSITIONS FOR CLUSTER GENERATION BY BRIDGE AMPLIFICATION | PARISI, JESSICA DANIELLE | 18d overdue |
| 17564592 | METHOD AND SYSTEM EMPLOYING DISTINGUISHABLE POLYMERASES FOR DETECTING TERNARY COMPLEXES AND IDENTIFYING COGNATE NUCLEOTIDES | LU, FRANK WEI MIN | 4d overdue |
| 17946742 | SYSTEMS AND METHODS OF DETECTING DENSELY-PACKED ANALYTES | TURK, NEIL N | 20d |
| 18613562 | DENSLEY-PACKED ANALYTE LAYERS AND DETECTION METHODS | TSAI, TSUNG YIN | 34d |
| 18587683 | COMPOSITIONS AND METHODS FOR DENSLEY-PACKED ANALYTE ANALYSIS | CROW, ROBERT THOMAS | — |
| 18419082 | COMPOSITIONS AND METHODS FOR AMPLIFYING POLYNUCLEOTIDES | BROWN, MINDY G | — |
| 18227657 | NUCLEIC ACID SEQUENCING METHOD AND SYSTEM EMPLOYING ENHANCED DETECTION OF NUCLEOTIDE-SPECIFIC TERNARY COMPLEX FORMATION | BERTAGNA, ANGELA MARIE | — |
| 18303905 | Sequencing Templates Comprising Multiple Inserts and Compositions and Methods for Improving Sequencing Throughput | HORLICK, KENNETH R | — |
| Art Unit | Apps |
|---|---|
| 1681 | 3 |
| 1683 | 3 |
| 1684 | 2 |
| 1693 | 2 |
| 2656 | 1 |
| 1685 | 1 |
| 1798 | 1 |
| 1682 | 1 |
| 1635 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 18613562 | DENSLEY-PACKED ANALYTE LAYERS AND DETECTION METHODS | TSAI, TSUNG YIN | 2656 | §102§103 | Final Rejection | 34d | Pending | Mar 22, 2024 |
| 18587683 | COMPOSITIONS AND METHODS FOR DENSLEY-PACKED ANALYTE ANALYSIS | CROW, ROBERT THOMAS | — | §103§112DP | Non-Final OA | — | Pending | Feb 26, 2024 |
| 18419082 | COMPOSITIONS AND METHODS FOR AMPLIFYING POLYNUCLEOTIDES | BROWN, MINDY G | 1685 | §103§112Other | Non-Final OA | — | Pending | Jan 22, 2024 |
| 18227657 | NUCLEIC ACID SEQUENCING METHOD AND SYSTEM EMPLOYING ENHANCED DETECTION OF NUCLEOTIDE-SPECIFIC TERNARY COMPLEX FORMATION | BERTAGNA, ANGELA MARIE | 1681 | §102§103§112DP | Non-Final OA | — | Pending | Jul 28, 2023 |
| 18139689 | METHODS AND COMPOSITIONS FOR CLUSTER GENERATION BY BRIDGE AMPLIFICATION | PARISI, JESSICA DANIELLE | 1684 | §102§103 | Non-Final OA | 18d overdue | Pending | Apr 26, 2023 |
| 18303905 | Sequencing Templates Comprising Multiple Inserts and Compositions and Methods for Improving Sequencing Throughput | HORLICK, KENNETH R | 1681 | §103§112 | Non-Final OA | — | Pending | Apr 20, 2023 |
| 18169970 | Sequence-Specific Targeted Transposition and Selection and Sorting of Nucleic Acids | PARISI, JESSICA DANIELLE | 1684 | §103§112 | Final Rejection | — | Pending | Feb 16, 2023 |
| 18146320 | FLOW CELLS AND METHODS | BERTAGNA, ANGELA MARIE | 1681 | §103§112 | Final Rejection | — | Pending | Dec 23, 2022 |
| 17946742 | SYSTEMS AND METHODS OF DETECTING DENSELY-PACKED ANALYTES | TURK, NEIL N | 1798 | §101§112 | Final Rejection | 20d | Pending | Sep 16, 2022 |
| 17859770 | PAIRED-END SEQUENCING METHODS AND COMPOSITIONS | VANN-OJUEKAIYE, KENDRA RAYCHELL | 1682 | §102§103§112 | Non-Final OA | — | Pending | Jul 07, 2022 |
| 17694404 | DETECTING METHYLCYTOSINE AND ITS DERIVATIVES USING S-ADENOSYL-L-METHIONINE ANALOGS (xSAMS) | HIBSHMAN, SARAH GRACE | 1693 | §102§103§112 | Non-Final OA | — | Pending | Mar 14, 2022 |
| 17564592 | METHOD AND SYSTEM EMPLOYING DISTINGUISHABLE POLYMERASES FOR DETECTING TERNARY COMPLEXES AND IDENTIFYING COGNATE NUCLEOTIDES | LU, FRANK WEI MIN | 1683 | §103§112 | Non-Final OA | 4d overdue | Pending | Dec 29, 2021 |
| 17555945 | METHODS AND COMPOSITIONS FOR NUCLEIC ACID SEQUENCING | HOPPE, EMMA RUTH | 1683 | §103 | Non-Final OA | 46d overdue | Pending | Dec 20, 2021 |
| 17525541 | ALTERING FLOW CELL SIGNALS | GIBBS, TERRA C | 1635 | DP | Non-Final OA | — | Pending | Nov 12, 2021 |
| 17478016 | REVERSIBLE MODIFICATION OF NUCLEOTIDES | LEE, HOI YAN NMN | 1693 | §103§112Other | Final Rejection | 9d | Pending | Sep 17, 2021 |
| 17338590 | SYSTEMS AND METHODS FOR SEQUENCING NUCLEOTIDES USING TWO OPTICAL CHANNELS | CROW, ROBERT THOMAS | 1683 | §103§112 | Non-Final OA | — | Pending | Jun 03, 2021 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free Trial